106 related articles for article (PubMed ID: 19322063)
1. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.
Vihinen MK; Kolho KL; Jänne OA; Andersson S; Raivio T
J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):504-6. PubMed ID: 19322063
[TBL] [Abstract][Full Text] [Related]
2. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
[TBL] [Abstract][Full Text] [Related]
3. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):789-94. PubMed ID: 17700265
[TBL] [Abstract][Full Text] [Related]
4. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica.
Cimmino MA; Andraghetti G; Briatore L; Salani B; Parodi M; Cutolo M; Cordera R
Ann N Y Acad Sci; 2010 Apr; 1193():160-3. PubMed ID: 20398023
[TBL] [Abstract][Full Text] [Related]
5. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P
J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin.
Corsi MM; Dogliotti G; Pedroni F; Galliera E; Malavazos AE; Villa R; Chiappelli M; Licastro F
Arch Gerontol Geriatr; 2009; 48(1):106-9. PubMed ID: 18207581
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis.
Hayakawa K; Ohashi H; Yokoyama H; Yoshida G; Okada M; Minatoguchi S
Nephrology (Carlton); 2009 Apr; 14(3):327-31. PubMed ID: 19207870
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids.
Vihinen MK; Kolho KL; Ashorn M; Verkasalo M; Raivio T
Eur J Endocrinol; 2008 Dec; 159(6):693-8. PubMed ID: 18787051
[TBL] [Abstract][Full Text] [Related]
11. Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later.
Kynde I; Heitmann BL; Bygbjerg IC; Andersen LB; Helge JW
Metabolism; 2009 Dec; 58(12):1817-24. PubMed ID: 19716142
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid sensitivity in inflammatory bowel disease.
Sidoroff M; Kolho KL
Ann Med; 2012 Sep; 44(6):578-87. PubMed ID: 21992564
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
14. Effect of individualized weight-loss programmes on adiponectin, leptin and resistin levels in obese adolescent boys.
Elloumi M; Ben Ounis O; Makni E; Van Praagh E; Tabka Z; Lac G
Acta Paediatr; 2009 Sep; 98(9):1487-93. PubMed ID: 19489770
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
Calcaterra V; De Amici M; Klersy C; Torre C; Brizzi V; Scaglia F; Albanesi M; Albertini R; Allais B; Larizza D
Acta Biomed; 2009 Aug; 80(2):117-23. PubMed ID: 19848048
[TBL] [Abstract][Full Text] [Related]
17. [Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process].
Krzesiek E; Pytrus T; Kosmowska A; Iwańczak B
Pol Merkur Lekarski; 2008 Dec; 25(150):455-9. PubMed ID: 19205373
[TBL] [Abstract][Full Text] [Related]
18. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases.
De Iudicibus S; Stocco G; Martelossi S; Londero M; Ebner E; Pontillo A; Lionetti P; Barabino A; Bartoli F; Ventura A; Decorti G
J Clin Gastroenterol; 2011 Jan; 45(1):e1-7. PubMed ID: 20697295
[TBL] [Abstract][Full Text] [Related]
19. Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery.
Matsuda A; Matsutani T; Sasajima K; Furukawa K; Tajiri T; Tamura K; Kogo H
J Surg Res; 2009 Dec; 157(2):227-34. PubMed ID: 19394964
[TBL] [Abstract][Full Text] [Related]
20. [Leptin-to-adiponectin ratio as a new marker associated with metabolic disease].
Kotani K; Sakane N
Nihon Rinsho; 2006 Dec; 64 Suppl 9():540-3. PubMed ID: 17458278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
